Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study.

Journal of the American Academy of Dermatology2025PMID: 40848975

Authors

Neubauer, Zachary; Ong, Michael M; Singal, Amit; Lipner, Shari R

glucagon-like peptide-1 receptor agonisthair lossobesitytelogen effluviumweight loss